Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Yungan Tao, J. Biau, X.S. Sun, C. Sire, Laurent Martin, M. Alfonsi and 19 more
- Rank
- 27 of 3,616
- Percentile
- top 0.8%
- Where
- Annals of Oncology, 2022
- Citations
- 199
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.